GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (FRA:BVF) » Definitions » Change In Receivables

Bausch Health (FRA:BVF) Change In Receivables : €-341 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Bausch Health Change In Receivables?

Bausch Health's change in receivables for the quarter that ended in Mar. 2024 was €-58 Mil. It means Bausch Health's Accounts Receivable increased by €58 Mil from Dec. 2023 to Mar. 2024 .

Bausch Health's change in receivables for the fiscal year that ended in Dec. 2023 was €-179 Mil. It means Bausch Health's Accounts Receivable increased by €179 Mil from Dec. 2022 to Dec. 2023 .

Bausch Health's Accounts Receivable for the quarter that ended in Mar. 2024 was €1,884 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Bausch Health's Days Sales Outstanding for the three months ended in Mar. 2024 was 86.80.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Bausch Health's liquidation value for the three months ended in Mar. 2024 was €-22,080 Mil.


Bausch Health Change In Receivables Historical Data

The historical data trend for Bausch Health's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Change In Receivables Chart

Bausch Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.10 139.74 -202.67 -53.81 -178.82

Bausch Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 100.87 -48.92 -216.45 -17.42 -57.96

Bausch Health Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-341 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bausch Health  (FRA:BVF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Bausch Health's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=1884.16/1980.76*91
=86.80

2. In Ben Graham's calculation of liquidation value, Bausch Health's accounts receivable are only considered to be worth 75% of book value:

Bausch Health's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=674.36-24920.04+0.75 * 1884.16+0.5 * 1505.12
=-22,080

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bausch Health Change In Receivables Related Terms

Thank you for viewing the detailed overview of Bausch Health's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch Health (FRA:BVF) Business Description

Traded in Other Exchanges
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health (FRA:BVF) Headlines

No Headlines